Joseph Weinstein, MD
Internal Medicine · North Easton, MANPI 1558346031
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $11,960 of the $14,130 with a category attached, or 84.6%. GSK accounts for 73.6% of it on its own, with 12 other manufacturers making up the rest. 2025 is the largest year on record at $6,315, more than ten times the $153 reported in 2020. Among internal medicine clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 24 payments — averaging $588.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$10K
- Sunovion Pharmaceuticals Inc.$2K
- Merck Healthcare Kgaa$700
- Anumana, Inc.$600
- Medtronic$281
- Johnson & Johnson$113
- plus $437 from 7 others
What the payments were for
- Consulting fees$11,96085%
- Speaking & faculty fees$1,72512%
- Food & beverage$3923%
- Gifts$530%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 2 | $10,400 |
| Sunovion Pharmaceuticals Inc. | 1 | $1,600 |
| Merck Healthcare Kgaa | 1 | $700 |
| Anumana, Inc. | 1 | $600 |
| Medtronic | 5 | $281 |
| Johnson & Johnson | 1 | $113 |
| United Therapeutics Corporation | 1 | $100 |
| Abiomed | 2 | $100 |
| Pfizer | 3 | $90 |
| AstraZeneca | 4 | $54 |
| Civica, Inc. | 1 | $53 |
| BD | 1 | $25 |
| Integra Lifesciences Corporation | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KYNMOBI$1,600
- ECG-AI LEF$600
- XARELTO$113
How this compares
$14,130 in reported general payments places this provider in the 95th percentile of 4,983 internal medicine providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 18 | $322 |
| Lisinopril | 18 | $190 |
| Alprazolam | 12 | $131 |
| Metformin Hcl | 11 | $100 |
| Amlodipine Besylate | 15 | $83 |
| Furosemide | 11 | $42 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in North Easton
- David SchenkeinBoston$5M
- Alan GarberCambridge$4.9M
- John FallonBoston$1.8M
- Michael MendelsohnBoston$1.6M
- Sandra RichmanBrookline$1.4M
- Gaurav SingalBoston$798K
- Asit ParikhBoston$486K
- Noopur RajeBoston$481K
- Daniel KuritzkesBoston$443K
- Xiuning leBoston$364K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.